» Articles » PMID: 2119495

Identification of an Estrogen Response Element Upstream of the Human C-fos Gene That Binds the Estrogen Receptor and the AP-1 Transcription Factor

Overview
Specialty Biochemistry
Date 1990 Sep 11
PMID 2119495
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Transcription of the proto-oncogene c-fos is stimulated by 17 beta-estradiol in estrogen responsive human and rat cells. To understand the molecular mechanisms of estrogen regulation of c-fos gene transcription, the human c-fos gene promoter, with 2.25 Kb of 5'-flanking DNA, was cloned upstream of the bacterial CAT gene and tested for estrogen regulation by transient transfection in HeLa cells. When an expression vector coding for the human estrogen receptor was co-transfected with the fos -CAT reporter, the promoter was found to respond to 17 beta-estradiol. An element responsible for estrogen induction was mapped in a 240 bp region localized 1060 to 1300 bases upstream of the startsite of transcription of the gene. Sequence analysis revealed, clustered in a 19 bp sub-region, a sequence corresponding to an imperfectly palindromic ERE: CGGCAGCGTGACC and two sequences: CTGAG and GTGAC, homologous to the core sequence of AP-1 transcription factor binding sites. A synthetic oligonucleotide reproducing this sub-region binds 'in vitro' both the estrogen receptor and AP-1 factor(s) and confers estrogen-responsivity to the HSV-tk gene promoter. Transcriptional activation by the estrogen receptor is prevented by mutations in the fos ERE that hamper binding of the receptor in vitro. Activation of the c-fos gene promoter in HeLa cells requires the DNA binding domain of the estrogen receptor, and can be achieved independently by the TAF-1 and the TAF-2 transcriptional activation functions of this molecule. A receptor mutant lacking the hormone binding domain can activate the c-fos gene promoter in the absence of estrogen.

Citing Articles

GPER: An Estrogen Receptor Key in Metastasis and Tumoral Microenvironments.

Tirado-Garibay A, Falcon-Ruiz E, Ochoa-Zarzosa A, Lopez-Meza J Int J Mol Sci. 2023; 24(19).

PMID: 37834441 PMC: 10573234. DOI: 10.3390/ijms241914993.


BC-N102 suppress breast cancer tumorigenesis by interfering with cell cycle regulatory proteins and hormonal signaling, and induction of time-course arrest of cell cycle at G1/G0 phase.

Lawal B, Kuo Y, Wu A, Huang H Int J Biol Sci. 2021; 17(12):3224-3238.

PMID: 34421361 PMC: 8375223. DOI: 10.7150/ijbs.62808.


Global View of Candidate Therapeutic Target Genes in Hormone-Responsive Breast Cancer.

Salvati A, Gigantino V, Nassa G, Cappa V, Ventola G, Cracas D Int J Mol Sci. 2020; 21(11).

PMID: 32517194 PMC: 7312026. DOI: 10.3390/ijms21114068.


Identification and characterization of novel and conserved microRNAs in several tissues of the Chinese rare minnow (Gobiocypris rarus) based on illumina deep sequencing technology.

Hong X, Qin J, Chen R, Yuan L, Zha J, Wang Z BMC Genomics. 2016; 17:283.

PMID: 27066897 PMC: 4828758. DOI: 10.1186/s12864-016-2606-5.


Sex differences in social modulation of learning in rats.

Mikosz M, Nowak A, Werka T, Knapska E Sci Rep. 2015; 5:18114.

PMID: 26655917 PMC: 4677340. DOI: 10.1038/srep18114.


References
1.
Bohmann D, Bos T, Admon A, Nishimura T, Vogt P, Tjian R . Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science. 1987; 238(4832):1386-92. DOI: 10.1126/science.2825349. View

2.
Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

3.
Sariban E, Mitchell T, Rambaldi A, Kufe D . c-sis but not c-fos gene expression is lineage specific in human myeloid cells. Blood. 1988; 71(2):488-93. View

4.
Wilding G, Lippman M, Gelmann E . Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells. Cancer Res. 1988; 48(4):802-5. View

5.
Martinez E, Givel F, Wahli W . The estrogen-responsive element as an inducible enhancer: DNA sequence requirements and conversion to a glucocorticoid-responsive element. EMBO J. 1987; 6(12):3719-27. PMC: 553842. DOI: 10.1002/j.1460-2075.1987.tb02706.x. View